- Home
- TISI vs INMB Comparison
TISI vs INMB Comparison
Compare TISI & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TISI
- INMB
- Stock Information
- Founded
- TISI 1973
- INMB 2015
- Country
- TISI United States
- INMB United States
- Employees
- TISI N/A
- INMB N/A
- Industry
- TISI Other Consumer Services
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- TISI Consumer Discretionary
- INMB Health Care
- Exchange
- TISI Nasdaq
- INMB Nasdaq
- Market Cap
- TISI 81.8M
- INMB 68.9M
- IPO Year
- TISI N/A
- INMB 2019
- Fundamental
- Price
- TISI $18.55
- INMB $2.01
- Analyst Decision
- TISI
- INMB Buy
- Analyst Count
- TISI 0
- INMB 4
- Target Price
- TISI N/A
- INMB $9.53
- AVG Volume (30 Days)
- TISI 8.2K
- INMB 782.5K
- Earning Date
- TISI 11-10-2025
- INMB 10-30-2025
- Dividend Yield
- TISI N/A
- INMB N/A
- EPS Growth
- TISI N/A
- INMB N/A
- EPS
- TISI N/A
- INMB N/A
- Revenue
- TISI $870,735,000.00
- INMB $50,000.00
- Revenue This Year
- TISI N/A
- INMB $142.83
- Revenue Next Year
- TISI N/A
- INMB $14,780.90
- P/E Ratio
- TISI N/A
- INMB N/A
- Revenue Growth
- TISI 2.55
- INMB N/A
- 52 Week Low
- TISI $11.12
- INMB $1.71
- 52 Week High
- TISI $26.77
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- TISI 49.27
- INMB 40.89
- Support Level
- TISI $18.93
- INMB $1.71
- Resistance Level
- TISI $19.85
- INMB $2.00
- Average True Range (ATR)
- TISI 0.83
- INMB 0.14
- MACD
- TISI -0.11
- INMB 0.03
- Stochastic Oscillator
- TISI 42.76
- INMB 44.78
About TISI Team Inc.
Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.